Annotated Medicine and Device Lists


Carbamazepine

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS QUE MODIFICAN LA LIBERACIÓN DEL PRINCIPIO ACTIVO
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 05.05. FÁRMACOS PARA EL DOLOR NEUROPÁTICO No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
PAHO Strategic Fund Medicine List 12.1. Oxytocics Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru 05. Anticonvulsants/Antiepileptics No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 03. ANTIEPILÉPTICOS No observations
Guyana. Essential Medicines List. 2020-2021 Other Anticonvulsants No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 28:12 Anti-convulsant agents No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants No observations
Barbados. Barbados National Drug Formulary (BNDF) 28.12.92 Miscellaneous Anticonvulsants No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 04.06.03 Neuropathic Pain No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 04.07.01 Control of Epilepsy No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 N. SISTEMA NERVOSO No observations
Bahamas. Drug Formulary 05.01 Anticonvulsants No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Cns Anticonvulsants-Miscellaneous No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 28. Anticonvulsivos No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 14. NEUROLOGIA No observations

This medicine is present in:

List Section Observation
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 03 ANTIEPILÉPTICOS No observations

This medicine is present in:

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 02.01 ANTICONVULSANTS No observations
Haiti. National List of Essential Medicines 24.02.02 Normothymics No observations
Barbados. Barbados National Drug Formulary (BNDF) 28.12.92 Miscellaneous Anticonvulsants No observations
Bahamas. Drug Formulary 05.01 Anticonvulsants No observations
Belize. National Drug Formulary 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 02.01 ANTICONVULSANTS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 14. NEUROLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 N. SISTEMA NERVOSO No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 04.06.03 Neuropathic Pain No observations

This medicine is present in:

List Section Observation
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants No observations

This medicine is present in:

List Section Observation
Ecuador Essential Medicines List - Ecuador No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Cns Anticonvulsants-Miscellaneous No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 90 TABLETAS.
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 03 ANTIEPILÉPTICOS No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 28. Anticonvulsivos No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 02.01 ANTICONVULSANTS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 14. NEUROLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 N. SISTEMA NERVOSO No observations
Paraguay. Lista de Medicamentos Esenciales. 2009 03. ANTIEPILÉPTICOS No observations
El Salvador - 2019 ANTIEPILÉPTICOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 05. ANTICONVULSIVANTES Y ANTIEPILÉPTICOS No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants No observations
Haiti. National List of Essential Medicines 24.02.02 Normothymics No observations
Barbados. Barbados National Drug Formulary (BNDF) 28.12.92 Miscellaneous Anticonvulsants No observations
Bahamas. Drug Formulary 05.01 Anticonvulsants No observations
Belize. National Drug Formulary 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 04.06.03 Neuropathic Pain No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
PAHO Strategic Fund Medicine List 12.1. Oxytocics No observations
Suriname. NGK-C-011 05. Anti-Convulsants/ Anti-Epileptics No observations
Suriname. NGK-C-011 25.3 Substances Used in Bipolar Disorder No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
PAHO Strategic Fund Medicine List 12.1. Oxytocics No observations
Suriname. NGK-C-011 05. Anti-Convulsants/ Anti-Epileptics No observations
Suriname. NGK-C-011 25.3 Substances Used in Bipolar Disorder No observations

This medicine is present in:

List Section Observation
Barbados. Barbados National Drug Formulary (BNDF) 28.12.92 Miscellaneous Anticonvulsants No observations
Bahamas. Drug Formulary 05.01 Anticonvulsants No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 04.07.01 Control of Epilepsy No observations

This medicine is present in:

List Section Observation
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 28:12 Anti-convulsant agents No observations
Bahamas. Drug Formulary 05.01 Anticonvulsants No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 04.07.01 Control of Epilepsy No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
WHO Model List of Essential Medicines (2021) 24.2.2. Medicines used in bipolar disorders No observations
PAHO Strategic Fund Medicine List 12.1. Oxytocics Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
WHO Model List of Essential Medicines (2021) 24.2.2. Medicines used in bipolar disorders No observations
PAHO Strategic Fund Medicine List 12.1. Oxytocics Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Peru 05. Anticonvulsants/Antiepileptics No observations
Peru 24.2.2 For Bipolar Disorder No observations
Guyana. Essential Medicines List. 2020-2021 Other Anticonvulsants No observations
Belize. National Drug Formulary 24.02.02 Medicines used in bipolar disorders No observations

This medicine is present in:

List Section Observation
Guyana. Essential Medicines List. 2020-2021 Other Anticonvulsants No observations

Information Resources: Carbamazepine

Loading ...
Loading ...
Loading ...
No information available